CACNA2D2 gene
Evidence from:
primary |
all sources
Related entities (8)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| CACNA2D2 | associated_with | ethanol group | — | 1 |
| CACNA2D2 | associated_with | migraine | — | 1 |
| CACNA2D2 | associated_with | neuropathic pain | — | 1 |
| CACNA2D2 | associated_with | opioid sensitivity | 0.029 | 1 |
| CACNA2D2 | risk_factor_for | opioid sensitivity | — | 1 |
| CACNA2D2 | associated_with | pain | — | 1 |
| CACNA2D2 | associated_with | psychiatric disorders | — | 1 |
| gabapentin | targets | CACNA2D2 | — | 1 |
Mentioned in (3)
Papers in which this entity is mentioned.
- Genome-wide association analyses identify 95 risk loci and provide insights into the neurobiology of post-traumatic stress disorder. (2024)
- Effects of chronic intermittent ethanol exposure and withdrawal on neuroblastoma cell transcriptome. (2020)
- Combined analysis of circulating β-endorphin with gene polymorphisms in OPRM1, CACNAD2 and ABCB1 reveals correlation with pain, opioid sensitivity and opioid-related side effects. (2013)
Merged raw entities (3)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| cacna2d2 | gene | 3 | 11 |
| calcium channel complex subunit gene | gene | — | — |
| calcium subunit cacna2d2 | gene | — | — |